Biology subjects

Metcalfe, J. Z.

Publications and source records attributed to Metcalfe, J. Z..

6 recordsLinked to original sources

bioRxiv2025

Paleogenomic insight into the collapse, recovery, and management of American bison

American bison were pushed to the brink of extinction by the 20th century. This bottleneck and the fragmented nature of remnant populations pose challenges to their resilience, as does human-facilitated admixture between bison subspecies and with cattle. To contextualize current diversity, we sequenced 115 ancient and 45 modern bison genomes from across North America dating back within the last [~]20,000 years. Past bison populations were highly connected, in contrast to structured modern herds. Modern wood bison carry plains bison ancestry from 1920s translocations, while many bison lack cattle ancestry that has previously been believed to be ubiquitous. Our findings reveal the legacy of human impacts on bison in the context of modern conservation and highlight the applicability of ancient DNA for guiding wildlife restoration.

evolutionary biology↗

bioRxiv2025

Beating the gold standard: A review of Mycobacterium tuberculosis lysis using bead beating and the need for standardization.

Bead beating is widely used for mechanical lysis of Mycobacterium tuberculosis, a bacterium with a highly resistant, lipid-rich cell wall. Despite its status as a de facto gold standard for mycobacterial lysis, there is no standardized protocol for bead beating, resulting in significant variability across studies. We conducted a literature review of 73 studies, identifying 38 with explicit mycobacterial bead beating protocols. Our analysis revealed heterogeneity in bead types, sizes, device models, and operational parameters, with 37% of studies failing to report critical details such as lysis speed. We experimentally assessed the impact of key variables--tube type, bead quantity, and device settings--on lysis efficiency using qPCR of M. tuberculosis DNA. Results showed that even minor changes, such as tube shape or bead volume, can significantly affect DNA yield. These findings underscore the need for standardized bead-beating protocols to improve reproducibility and comparability. Future efforts should prioritize developing consensus methods tailored to sample type and analytical application.

molecular biology↗

bioRxiv2025

Unpacking bedaquiline hetero-resistance: the importance of intermediate profiles for phenotypic drug-susceptibility testing

Phenotypic drug susceptibility testing (pDST) remains the gold standard for Mycobacterium tuberculosis complex drug resistance determination. Next generation sequencing technologies can identify heteroresistant populations at low frequencies, but little is known about the impact of heteroresistance on bedaquiline (BDQ) pDST results. We simulated heteroresistance using in vitro generated MmpR5 mutants mixed with the progenitor strain at various percentages (1-20%) and did pDST using MGIT960 culture (1 and 2 {micro}g/mL BDQ concentrations). Targeted Next Generation Sequencing (tNGS) was used to quantify the mutant sub-population in growth control tubes, which were expected to maintain the mutant: wild type proportion throughout the assay. Growth units of these growth control tubes were also comparable with minor differences in time-to-positivity between ratio mixtures. Only when intermediate results were considered could BDQ heteroresistance be detected at frequencies of approximately 1% by pDST at a critical concentration of 1 {micro}g/mL using BACTEC MGIT960 coupled with EpiCenter TBeXiST software. The ability of pDST, a widely available DST technique, to reveal the presence of BDQ-resistant subpopulations at the phenotypic testing stage could improve resistance determination and potentially reduce time to effective treatment. ImportanceMultidrug resistant tuberculosis (MDR-TB) is estimated to cause up to 19% of all antimicrobial resistance-attributable deaths worldwide. Further, the success rate for the treatment of drug-resistant TB, in the presence of adherence, is poor at only 68%. The advent of bedaquiline (BDQ) has revolutionized MDR-TB care, but BDQ resistance determination is hampered by several obstacles facing both phenotypic and genotypic testing. Specifically for phenotypic susceptibility testing, BDQ-resistant Mycobacterium tuberculosis isolates with variants in MmpR5, which may display minimal inhibitory concentration values just below the critical concentration or are present at low frequencies (heteroresistance; the presence of mixed mutant and wild-type populations within a specimen), are typically designated as susceptible. This may lead to prescription of an ineffective regimen and amplification of resistance. The BACTEC MGIT960 platform coupled with EpiCenter TBeXiST software for phenotypic testing, which is currently the only routinely used method of BDQ DST, can be used to derive more information about underlying resistant populations. We demonstrate how this is possible through the consideration of intermediate results (i.e., when growth units in a drug-containing tube reach the threshold for resistance but only after a further week of incubation). These intermediate results, commonly disregarded by TB laboratories, could lead to earlier detection of BDQ resistance. This is especially crucial when the genetic mechanism of resistance is unknown, a variant has not been associated with resistance in the interim, and in cases of heteroresistance.

microbiology↗

bioRxiv2025

URAdime - a tool for analyzing primer sequences in sequencing data to identify dimers and super-amplicons.

Targeted sequencing of multiplex PCR amplicons is commonplace in research laboratories and clinical diagnostics. There are numerous tools for the a priori optimization of primers and reactions, but no tools to detect specific problematic primers post hoc. We developed URAdime, a tool for analyzing primer sequences in sequencing data to identify dimers and super-amplicons. We show that it successfully detects these unwanted amplicons and accurately attributes their generation to specific primers.

bioinformatics↗

bioRxiv2024

spotPCR: A Rapid and Efficient Approach for Indexing Individual Template Molecules using Unique Molecular Identifiers

Low-frequency mutations provide valuable insights in various fields, including drug resistance identification, cancer and infectious disease research. One promising strategy to enhance the sensitivity and specificity of mutation detection is the incorporation of unique molecular identifiers (UMIs) during polymerase chain reaction (PCR) amplification and before deep sequencing. However, conventional methods for UMI incorporation oRen necessitate multiple labor-intensive steps. spotPCR (Specific Primer Limited Unique Molecular Identifier Tagging PCR) overcomes these challenges, streamlining the UMI tagging process.

molecular biology↗

bioRxiv2022

Circularization of rv0678 for genotypic bedaquiline resistance testing of Mycobacterium tuberculosis

Circular DNA offers benefits over linear DNA in diagnostic and field assays, but currently, circular DNA generation is lengthy, inefficient, highly dependent on the length and sequence of DNA, and can result in unwanted chimeras. We present streamlined methods for generating PCR-targeted circular DNA from a 700bp amplicon of rv0678, the high GC content (65%) gene implicated in Mycobacterium tuberculosis bedaquiline resistance, and demonstrate that these methods work as desired. We employ self-circularization with and without splints, a Gibson cloning-based approach, and novel two novel methods for generating pseudocircular DNA. The circular DNA can be used as a template for rolling circle PCR followed by long-read sequencing, allowing for the error correction of sequence data, and improving the confidence in the drug resistance determination and strain identification; and ultimately improving patient treatment.

molecular biology↗